(Q44597163)

4 December 2017

title

A novel model measuring the harm of transplanting hepatocellular carcinoma exceeding Milan criteria (English)

1 reference

4 December 2017

main subject

hepatocellular carcinoma

1 reference

M L Volk

1

1 reference

4 December 2017

S Vijan

series ordinal

2

1 reference

4 December 2017

J A Marrero

series ordinal

3

1 reference

4 December 2017

language of work or name

English

0 references

publication date

2 March 2008

1 reference

American Journal of Transplantation

4 December 2017

published in

1 reference

4 December 2017

volume

8

1 reference

4 December 2017

issue

4

1 reference

4 December 2017

page(s)

839-846

1 reference

Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis

4 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2007.02138.X

Living donor liver transplantation for hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2007.02138.X

Management of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2007.02138.X

Hepatocellular carcinoma in the United States. Prognostic features, treatment outcome, and survival.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2007.02138.X

Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2007.02138.X

Liver transplantation for hepatocellular carcinoma: comparison of the proposed UCSF criteria with the Milan criteria and the Pittsburgh modified TNM criteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2007.02138.X

Liver transplantation for hepatocellular carcinoma: is expansion of criteria justified?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2007.02138.X

Expanded criteria for hepatocellular carcinoma: down-staging with a view to liver transplantation--yes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2007.02138.X

Geographic differences in event rates by model for end-stage liver disease score

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2007.02138.X

Regional variations in peer reviewed liver allocation under the MELD system

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2007.02138.X

A systematic review of the performance of the model for end-stage liver disease (MELD) in the setting of liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2007.02138.X

A clinically based discrete-event simulation of end-stage liver disease and the organ allocation process.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2007.02138.X

Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2007.02138.X

Prospective cohort study of transarterial chemoembolization for unresectable hepatocellular carcinoma in 8510 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2007.02138.X

Expanded criteria for liver transplantation in patients with hepatocellular carcinoma: a report from the International Registry of Hepatic Tumors in Liver Transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2007.02138.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2007.02138.X

An empirical comparison of EQ-5D and SF-6D in liver transplant patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2007.02138.X

Assessing health-related quality of life pre- and post-liver transplantation: a prospective multicenter study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2007.02138.X

Distributing scarce livers: the moral reasoning of the general public.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2007.02138.X

Optimizing staging for hepatocellular carcinoma before liver transplantation: A retrospective analysis of the UNOS/OPTN database

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2007.02138.X

Genes associated with progression and recurrence of hepatocellular carcinoma in hepatitis C patients waiting and undergoing liver transplantation: preliminary results.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2007.02138.X

Liver transplantation criteria for hepatocellular carcinoma should be expanded: a 22-year experience with 467 patients at UCLA

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2007.02138.X

Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2007.02138.X

Waiting list removal rates among patients with chronic and malignant liver diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2007.02138.X

Liver transplantation for hepatocellular carcinoma: the MELD impact.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2007.02138.X

Natural history of untreated nonsurgical hepatocellular carcinoma: rationale for the design and evaluation of therapeutic trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2007.02138.X

Living donor liver transplantation for early hepatocellular carcinoma: A life-expectancy and cost-effectiveness perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2007.02138.X

Health status versus utilities of patients with end-stage liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2007.02138.X

10.1111/J.1600-6143.2007.02138.X

21 January 2018

Identifiers

DOI

1 reference

4 December 2017

1 reference